in
  1. Ligthelm R, Davidson J. Initiating insulin in primary care--the role of modern premixed formulations. Prim Care Diabetes. 2008;2:9-16.[abstract]
  2. Garber AJ. Premixed insulin analogues for the treatment of diabetes mellitus. Drugs. 2006;66:31-49. [abstract]
  3. Qayyum R, Bolen S, Maruthur N, et al. Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes. Ann Intern Med. 2008;149:549-559. [abstract]
  4. Rizvi AA, Ligthelm RJ. The use of premixed insulin analogues in the treatment of patients with type 2 diabetes mellitus: advantages and limitations. Insulin. 2007;2:68-79.[abstract]
  5. Levy P. Insulin analogs or premixed insulin analogs in combination with oral agents for treatment of type 2 diabetes. Medscape Gen Med. [Epub 2007 April 16.] [abstract]
  6. Polonsky KS, Given BD, Hirsch LJ, et al. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med. 1988;318:1231-1239. [abstract]
  7. Sharplin P, Gordon J, Peters JR, Tetlow AP, Longman AJ, McEwan P. Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational study. Cardiovasc Diabetol. 2009;8:3. [Epub 2009 Jan 19.] [abstract]
Copyright © 2010, 2011  Perelman School of Medicine at the University of Pennsylvania Office of Continuing Medical Education & BestPractice CPD, LLC®. All rights reserved.